Kardiyovasküler ve Solunum Hastalığı Olan Hastaların Anestezi Yönetimi
Özet
Kardiyovasküler ve solunum sistemi hastalıkları, anestezi yönetiminde en çok dikkat edilmesi gereken konuların başında gelmektedir. Kardiyovasküler sistem, doku ve özellikle hayati organlara oksijen taşıyarak yaşamsal fonksiyonların sürdürülmesini sağlamaktadır. Bu sistemle ilişkili hastalıklar, hem bu sistemin kendi hastalıkları olan primer nedenlerle hem de hipertiroidizm veya şok gibi sekonder nedenlerle ortaya çıkabilir. Rutinde kullanılan anestezik ajanların kardiyovasküler sistem üzerindeki etkileri ciddi ve hayati komplikasyonlara neden olabileceğinden, bu hastalarda anestezik ilaç seçimi büyük titizlikle yapılmalı, gerekirse inotropik ajanlarla destek sağlanmalıdır. Aynı şekilde, solunum sistemi hastalıkları da anestezi sırasında hayati risk oluşturabilir. Hava yolu tıkanıklıkları, laringeal felç, pulmoner ödem ve pnömotoraks gibi solunum sistemini direkt etkileyen durumlar oksijenasyon ve ventilasyonu zorlaştırabilir. Özellikle inhalasyon anestezikleri solunumu aktif olarak baskılayabildiği için, hastaların genel durumu göz önünde bulundurularak en uygun anestezi yöntemi seçilmelidir. Solunum sistemi anatomisinin iyi bilinmesi, uygun ve doğru ekipmanların kullanımı ve dikkatli hasta takibi, başarılı bir anestezi süreci için zorunludur. Kardiyovasküler ve solunum sistemi hastalıklarında bireysel protokollerin oluşturulması, komplikasyon riskini azaltarak hasta güvenliğini artırır.
Cardiovascular and respiratory system diseases are among the most critical issues requiring attention in anesthesia management. The cardiovascular system ensures the maintenance of vital functions by transporting oxygen to tissues and especially vital organs. Diseases related to this system may arise both from primary causes that are inherent to the system itself and from secondary causes such as hyperthyroidism or shock. Since the effects of routinely used anesthetic agents on the cardiovascular system may lead to serious and life-threatening complications, anesthetic drug selection in these patients must be carried out with great care, and inotropic support should be provided when necessary. Similarly, respiratory system diseases may also pose life-threatening risks during anesthesia. Conditions that directly affect the respiratory system, such as airway obstructions, laryngeal paralysis, pulmonary edema, and pneumothorax, can impair oxygenation and ventilation. As inhalation anesthetics can actively depress respiration, the most appropriate anesthetic technique should be selected by considering the patient's overall health status.
A thorough understanding of the respiratory system anatomy, the use of proper and suitable equipment, and close patient monitoring are essential for a successful anesthesia process.
The development of individualized protocols in cardiovascular and respiratory system diseases reduces the risk of complications and enhances patient safety.
Referanslar
Andree RA. Sudden death following naloxone administration. Anesth Analg 59: 782–784, 1980.
Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders. In: Goodman & Gilman’s the Pharmacological Basis of Therapeutics, 10th ed. J.G. Hardman and L.E. Limbird, eds. New York: McGraw-Hill, pp 485–520, 2001
Basile JN, Bloch MJ. Identifying and managing factors that interfere with or worsen blood pressure control. Postgrad Med. 122(2): 35–48, 2010.
Bovill JG. Intravenous anesthesia for the patient with left ventricular dysfunction. Semin. Cardiothorac. Vasc. Anesth. 10(1): 43–48, 2006.
Brodbelt DC, Blissitt KJ, Hammond RA, et al. The risk of death: the confidential enquiry into perioperative small animal fatalities. Vet. Anaesth. Analg. 35(5): 365–373, 2008.
Calò L, De Ruvo E, Sette A, et al. Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications. J. Cardiovasc. Med. 8(3): 138–143, 2007.
Congdon JM. Cardiovascular Disease, Canine and Feline Anesthesia and Co-Existing Disease. Second Ed. Ed: Johnson RA, Snyder RBC, Schroeder CA,Wiley Blackwell, USA, (1):1-68, 2022.
Copland VS, Haskins SC, Patz J. Naloxone reversal of oxymorphone effects in dogs. Am J Vet Res. 50: 1854–1858, 1989.
Elkama A. Geriatrik Kedi Ve Köpeklerde Anestezi Protokolü, Cerrahi Anabilim Dalı Tezsiz Yüksek Lisans Dönem Projesi, Ankara, 2008.
Evans AT, Wilson DV. Anesthetic emergencies and procedures. In: Tranquilli WJ, Thurmon JC, Grimm KG, eds. Lumb and Jones veterinary anesthesia and analgesia. 4th ed. Ames: Blackwell; 1033–48, 2007.
Evers AS, Crowder CM. General anesthestics. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 100th ed. J.G. Hardman and L.E. Limbird, eds. New York: McGraw-Hill, pp 337–366, 2001.
Glowaskı MM. Anesthesia For The Geriatric Patient. Tufts University North Grafton, Ma, Usa, 2002.
Grubb T. Anesthesia for Patients with Respiratory Disease and/or Airway Compromise, College of Veterinary Medicine, Veterinary Clinical Sciences, Pullman, USA, doi:10.1053/j.tcam.2010.01.001, 2010.
Grubb TL, Greene SA. Essentials Of Small Animal Anesteshia And Analgesia, Anesthesia For Patients With Respiratory Disease And/Or Airway Compromise, 2nd ed, Tranquilli WJ, Lamont LA, Grimm KA, eds., Wiley Blackwell, West Sussex, 2011.
Grubb TL. Greene SA. Essentials Of Small Animal Anesteshia And Analgesia, Anesthesia for patients with cardiovascular disease 2nd ed, Tranquilli WJ, Lamont LA, Grimm KA, eds.,Wiley Blackwell, West Sussex, 2011.
Gutstein HB, Akil H. Opioid analgesics. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 10th ed. J.G. Hardman and L.E. Limbird, eds. New York: McGrawHill, pp 569–620, 2001.
Günay C, Balıkçı E. Köpeklerde Propofol Ve Đsofluran Anesteziklerinin Bazı Klinik Ve Elektrokardiyografik (Ekg) Bulgular Üzerine Etkilerinin Karşılaştırılması. Kafkas Üni. Vet. Fak. Derg. 7 (1): 87-93, 2001.
Güzel Ö, Perk CE. Köpeklerde Genel Anestezi Prosedürü Ve İntraoperatif Periyotta Rastlanan Kardiyak Ritm Bozukluklarının Tanı Ve Sağaltımı. İstanbul Üni. Vet. Fak. Derg. 28 (2): 381-401, 2002.
Haskins SC, Farver TB, Patz JD. Cardiovascular changes in dogs given diazepam and diazepa-ketamine. Am J Vet Res. 17: 795–798, 1986.
Haskins SC. Monitoring The Anaesthetized Patients. Chapter 15: Lump and Jones’ Veterinary Anesthesia. Third Ed. Ed: Thurmon ve ark. Williams and Wilkins Co. U.S.A. p.: 409-424, 1996.
Johnson RA, Brunson DB. Respiratory Disease, Canine and Feline Anesthesia and Co-Existing Disease. Second Ed. Ed: Johnson RA, Snyder RBC, Schroeder CA, Wiley Blackwell, USA, (2):86-105, 2022.
Johnson R, Snyder LBC, Schroeder CA. Canine and Feline Anesthesia and Co-Existing Disease, (1):22, 2022.
Kroenke K, Lawrence VA, Theroux JF, et al. Operative risk in patients with severe obstructive disease. Arch Intern Med. 152(5): 967–971, 1992.
Ko JC. Anesthesia monitoring and management, A Color Handbook Small Animal Anesthesia And Pain Management, Third Ed. Ed: Ko JC, Crc Press, USA, (6):101-136, 2025.
Ko JC, Weil AB. Anesthetic considerations for airway and thoracic surgery with emphasis on optimal airway management and ventilation, A Color Handbook Small Animal Anesthesia And Pain Management, Third Ed. Ed: Ko JC, Crc Press, USA, (12):229-241, 2025.
Lemke KA. Anticholinergics and sedatives. In: Lumb & Jones ‘ Veterinary Anesthesia and Analgesia, 4th ed. W.J. Tranquilli, J.C. Thurmon, and K.A. Grimm, eds. Ames, IA: Blackwell Publishing, pp 203–239, 2007.
Lemmens S, Stienen PJ, Jaramillo LG, et al. The cardiorespiratory effects of a fentanyl infusion following acepromazine and glycopyrrolate in dogs. Tijdschr Diergeneeskd 133(21): 888–895, 2008.
Lenhardt R. The effect of anesthesia on body temperature control. Front Biosci 2: 1145– 1154, 2010.
Lerche P, Muir WW. Effect of medetomidine on breathing and inspiratory neuromuscular drive in conscious dogs. Am J Vet Res. 65(6): 720–724, 2004.
Michealis LL, Hickey PR, Clark TA, et al. Ventricular irritability associated with the use of naloxone hydrochloride. Ann Thorac Surg. 18: 608–614, 1974.
Mitchell SL, McCarthy R, Rudloff E, et al. Tracheal rupture associated with intubation in cats: 20 cases (1996–1998). J Am Vet Med Assoc. 216(10): 1592–1595, 2000.
Musk GC, Pang DS, Beths T, et al. Target-controlled infusion of propofol in dogsevaluation of four targets for induction of anaesthesia. Vet Rec. 157(24): 766–770, 2005.
Perk C. Monitorizasyon Yöntemleri. İstanbul Veteriner Hekimler Odası Dergisi. 2, (2): 32-36, 2000.
Sager J, McKune CM. Anesthesia Equipment And Monitoring Small Animal Anesthesia Techniques, Second Ed. Ed: Shelby AM, Mckune CM, Wiley Blackwell, USA, (2):28-51, 2023.
Scarabelli S. Anaesthesia of the patient with cardiovascular disease part 1: risk assessment, Companion Animal. 21(5) : 280-284, 2016.
Smıth AJ, Gaynor SJ, Bednarskı MR, Muır WW. Adverse Effects Of Administration Of Propofol With Various Preanesthetic Regimens İn Dogs. Javma. 202(7): 1111-1115, 1993.
Skarda RT, Tranquilli WJ. Local and regional anesthetic and analgesic techniques: dogs. In: Lumb & Jones Veterinary Anesthesia, 4th ed. W.J. Tranquilli, J.C. Thurmon, and K.A. Grimm, eds. Ames, IA: Wiley-Blackwell, pp 561–595, 2007.
Stepien RL, Bonagura JD, Bednarski RM, et al. Cardiorespiratory effects of acepromazine maleate and buprenorphine hydrochloride in clinically normal dogs. Am J Vet Res. 56(1): 78–84, 1995.
Stoelting RK. Nonbarbiturate induction drugs. In: Pharmacology and Physiology in VetBooks.ir Anesthetic Practice, 3rd ed. R.K. Stoelting, ed. Philadelphia, PA: Lippincott, Williams & Wilkins, pp 140–157, 1999.
Stoelting RK. Inhaled anesthetics. In: Pharmacology and Physiology in Anesthetic Practice, 3rd ed. R.K. Stoelting, ed. Philadelphia, PA: Lippincott, Williams & Wilkins, pp 36–76, 1999.
Stoelting RK. Benzodiazepines. In: Pharmacology and Physiology in Anesthetic Practice, 4th ed. R.K. Stoelting, ed. Philadelphia, PA: Lippincott, Williams & Wilkins, pp 140– 154, 2006.
Thompson JS. The role of epidural analgesia and anesthesia in surgical outcomes. Adv Surg 36: 297–307, 2002.
